Roche Sales Hurt by Strong Franc

Swiss drug maker Roche reported a 1% dip in first-quarter sales, as a strong Swiss franc eroded the value of growing sales of its cancer drugs.

Leave a Reply

Your email address will not be published. Required fields are marked *